[{"data": {"name": "Analysis of the potential effect of ponatinib on the QTc interval in patients with refractory hematological malignancies", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Daryl Sonnichsen", "@type": "Person"}, {"name": "David J. Dorer", "@type": "Person"}, {"name": "Jorge Cortes", "@type": "Person"}, {"name": "Moshe Talpaz", "@type": "Person"}, {"name": "Michael W. Deininger", "@type": "Person"}, {"name": "Neil P. Shah", "@type": "Person"}, {"name": "Hagop M. Kantarjian", "@type": "Person"}, {"name": "Dale Bixby", "@type": "Person"}, {"name": "Michael J. Mauro", "@type": "Person"}, {"name": "Ian W. Flinn", "@type": "Person"}, {"name": "Jeffrey Litwin", "@type": "Person"}, {"name": "Christopher D. Turner", "@type": "Person"}, {"name": "Frank G. Haluska", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://link.springer.com/content/pdf/10.1007%2Fs00280-013-2160-7.pdf", "encodingFormat": "application/pdf"}, {"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc3668123?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Springer Science and Business Media LLC", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1007/s00280-013-2160-7", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCXGEdspsqXSn-CTbrQax6X6B1n-CD3QvxRLuMRdZ-CRLaTxGDAJD6D", "propertyID": "ISCC"}], "datePublished": "2013-04-23"}, "schema": "schema.org", "mediatype": "application/ld+json"}]